Company |
Amount raised |
Intarcia Therapeutics Inc. |
$200M |
Juno Therapeutics Inc. |
$134M |
Adaptimmune Ltd. |
$104M |
Cell Medica Ltd. |
$78M |
Beigene Ltd. |
$75M |
Spark Therapeutics Inc. |
$72.8M |
Melinta Therapeutics Inc. |
$70M |
Novimmune SA |
$66M |
C3 Jian Inc. |
$60.5M |
Kolltan Pharmaceuticals Inc. |
$60M |
Kempharm Inc. |
$60M |
Viamet Pharmaceuticals Holdings LLC |
$60M |
Ascendis Pharma A/S |
$60M |